{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:59:03Z","timestamp":1784527143258,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41401-018-0209-1","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T14:03:54Z","timestamp":1549461834000},"page":"991-998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["NLRP3 inflammasome pathway is involved in olfactory bulb pathological alteration induced by MPTP"],"prefix":"10.1038","volume":"40","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-hang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-he","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"209_CR1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912.","journal-title":"Lancet"},{"key":"209_CR2","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8:1150\u20137.","journal-title":"Lancet Neurol"},{"key":"209_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"209_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00401-017-1726-6","volume":"134","author":"BG Trist","year":"2017","unstructured":"Trist BG, Davies KM, Cottam V, Genoud S, Ortega R, Roudeau S, et al. Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson\u2019s disease brain. Acta Neuropathol. 2017;134:113\u201327.","journal-title":"Acta Neuropathol"},{"key":"209_CR5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51:745\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"209_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-013-1144-3","volume":"126","author":"IC Mundinano","year":"2013","unstructured":"Mundinano IC, Hernandez M, Dicaudo C, Ordonez C, Marcilla I, Tunon MT, et al. Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys. Acta Neuropathol. 2013;126:411\u201325.","journal-title":"Acta Neuropathol"},{"key":"209_CR7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nbd.2016.12.013","volume":"109","author":"NL Rey","year":"2018","unstructured":"Rey NL, Wesson DW, Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis. 2018;109:226\u201348.","journal-title":"Neurobiol Dis"},{"key":"209_CR8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","volume":"126","author":"NL Rey","year":"2013","unstructured":"Rey NL, Petit GH, Bousset L, Melki R, Brundin P. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 2013;126:555\u201373.","journal-title":"Acta Neuropathol"},{"key":"209_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-015-1451-y","volume":"130","author":"GU Hoglinger","year":"2015","unstructured":"Hoglinger GU, Alvarez-Fischer D, Arias-Carrion O, Djufri M, Windolph A, Keber U, et al. A new dopaminergic nigro-olfactory projection. Acta Neuropathol. 2015;130:333\u201348.","journal-title":"Acta Neuropathol"},{"key":"209_CR10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.neurobiolaging.2008.07.006","volume":"31","author":"NM Kanaan","year":"2010","unstructured":"Kanaan NM, Kordower JH, Collier TJ. Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys. Neurobiol Aging. 2010;31:937\u201352.","journal-title":"Neurobiol Aging"},{"key":"209_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.31887\/DCNS.2017.19.1\/rpal","volume":"19","author":"PC Tiwari","year":"2017","unstructured":"Tiwari PC, Pal R. The potential role of neuroinflammation and transcription factors in Parkinson disease. Dialog-Clin Neurosci. 2017;19:71\u201380.","journal-title":"Dialog-Clin Neurosci"},{"key":"209_CR12","first-page":"1817","volume":"41","author":"JD Guo","year":"2018","unstructured":"Guo JD, Zhao X, Li Y, Li GR, Liu XL. Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease (Review). Int J Mol Med. 2018;41:1817\u201325.","journal-title":"Int J Mol Med"},{"key":"209_CR13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuint.2018.07.003","volume":"120","author":"R Niranjan","year":"2018","unstructured":"Niranjan R. Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration. Neurochem Int. 2018;120:13\u201320.","journal-title":"Neurochem Int"},{"key":"209_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229\u201365.","journal-title":"Annu Rev Immunol"},{"key":"209_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2015.07.058","volume":"294","author":"Y Liu","year":"2015","unstructured":"Liu Y, Sun JD, Song LK, Li J, Chu SF, Yuan YH, et al. Environment-contact administration of rotenone: A new rodent model of Parkinson\u2019s disease. Behav Brain Res. 2015;294:149\u201361.","journal-title":"Behav Brain Res"},{"key":"209_CR16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.117.244020","volume":"363","author":"QS Zhang","year":"2017","unstructured":"Zhang QS, Heng Y, Chen Y, Luo P, Wen L, Zhang Z, et al. A novel bibenzyl compound (20C) protects mice from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\/probenecid toxicity by regulating the alpha-synuclein-related inflammatory response. J Pharmacol Exp Ther. 2017;363:284\u201392.","journal-title":"J Pharmacol Exp Ther"},{"key":"209_CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.54.5.388","volume":"54","author":"WR Gibb","year":"1991","unstructured":"Gibb WR, Lees AJ. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1991;54:388\u201396.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"209_CR18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/ene.12117","volume":"20","author":"AJ Clark","year":"2013","unstructured":"Clark AJ, Ritz B, Prescott E, Rod NH. Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson\u2019s disease: a prospective cohort study. Eur J Neurol. 2013;20:1113\u201320.","journal-title":"Eur J Neurol"},{"key":"209_CR19","first-page":"669","volume":"15","author":"M Shiba","year":"2000","unstructured":"Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, et al. Anxiety disorders and depressive disorders preceding Parkinson\u2019s disease: a case-control study. Movement disorders: official journal of the Movement Disorder. Society. 2000;15:669\u201377.","journal-title":"Society"},{"key":"209_CR20","first-page":"212","volume":"15","author":"CW Olanow","year":"2000","unstructured":"Olanow CW, Schapira AH, Roth T. Waking up to sleep episodes in Parkinson\u2019s disease. Movement disorders: official journal of the Movement Disorder. Society. 2000;15:212\u20135.","journal-title":"Society"},{"key":"209_CR21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1468-1331.2008.02148.x","volume":"15","author":"NI Bohnen","year":"2008","unstructured":"Bohnen NI, Studenski SA, Constantine GM, Moore RY. Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study. Eur J Neurol. 2008;15:685\u201391.","journal-title":"Eur J Neurol"},{"key":"209_CR22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrn.2017.91","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18:509.","journal-title":"Nat Rev Neurosci"},{"key":"209_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2009.02.006","volume":"453","author":"L Silveira-Moriyama","year":"2009","unstructured":"Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W, et al. Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett. 2009;453:77\u201380.","journal-title":"Neurosci Lett"},{"key":"209_CR24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, White CL 3rd, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, et al. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol. 2009;117:169\u201374.","journal-title":"Acta Neuropathol"},{"key":"209_CR25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979\u201380.","journal-title":"Science"},{"issue":"5","key":"209_CR26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0166-2236(89)90066-0","volume":"12","author":"Roger Barker","year":"1989","unstructured":"Barker, R. Environmental toxins and Parkinson\u2019s disease. Trends Neurosci. 1989;12:182\u20133.","journal-title":"Trends in Neurosciences"},{"key":"209_CR27","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","volume":"35","author":"PH Weinreb","year":"1996","unstructured":"Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr. NACP, a protein implicated in Alzheimer\u2019s disease and learning, is natively unfolded. Biochemistry. 1996;35:13709\u201315.","journal-title":"Biochemistry"},{"key":"209_CR28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839\u201340.","journal-title":"Nature"},{"key":"209_CR29","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Newman AJ, Soldner F, Luth ES, Kim NC, von Saucken VE, et al. Parkinson-causing alpha-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015;6:7314.","journal-title":"Nat Commun"},{"key":"209_CR30","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","volume":"28","author":"HM Gao","year":"2008","unstructured":"Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM. Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci: Off J Soc Neurosci. 2008;28:7687\u201398.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"issue":"9","key":"209_CR31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.neurol.2018.08.002","volume":"174","author":"R. Melki","year":"2018","unstructured":"Melki R. Alpha-synuclein and the prion hypothesis in Parkinson's disease. Revue neurologique 2018;174:644-52.","journal-title":"Revue Neurologique"},{"key":"209_CR32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777\u201383.","journal-title":"Science"},{"key":"209_CR33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72:893\u2013901.","journal-title":"Ann Neurol"},{"key":"209_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","volume":"40","author":"A Roy","year":"2016","unstructured":"Roy A, Srivastava M, Saqib U, Liu D, Faisal SM, Sugathan S, et al. Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways. Int Immunopharmacol. 2016;40:79\u201389.","journal-title":"Int Immunopharmacol"},{"key":"209_CR35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jlb.67.4.508","volume":"67","author":"A Bowie","year":"2000","unstructured":"Bowie A, O\u2019Neill LA. The interleukin-1 receptor\/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol. 2000;67:508\u201314.","journal-title":"J Leukoc Biol"},{"key":"209_CR36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","volume":"14","author":"AS Baldwin Jr","year":"1996","unstructured":"Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649\u201383.","journal-title":"Annu Rev Immunol"},{"key":"209_CR37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8:49\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"209_CR38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783\u2013801.","journal-title":"Cell"},{"key":"209_CR39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nchembio.1788","volume":"11","author":"L Li","year":"2015","unstructured":"Li L, Liu Y, Chen HZ, Li FW, Wu JF, Zhang HK, et al. Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation. Nat Chem Biol. 2015;11:339\u201346.","journal-title":"Nat Chem Biol"},{"key":"209_CR40","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20140654","volume":"212","author":"MS Baig","year":"2015","unstructured":"Baig MS, Zaichick SV, Mao M, de Abreu AL, Bakhshi FR, Hart PC, et al. NOS1-derived nitric oxide promotes NF-kappaB transcriptional activity through inhibition of suppressor of cytokine signaling-1. J Exp Med. 2015;212:1725\u201338.","journal-title":"J Exp Med"},{"key":"209_CR41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","volume":"21","author":"K Takeda","year":"2003","unstructured":"Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335\u201376.","journal-title":"Annu Rev Immunol"},{"key":"209_CR42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ni.2231","volume":"13","author":"L Franchi","year":"2012","unstructured":"Franchi L, Munoz-Planillo R, Nunez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol. 2012;13:325\u201332.","journal-title":"Nat Immunol"},{"key":"209_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2018.02.003","volume":"288","author":"L Wen","year":"2018","unstructured":"Wen L, Zhang QS, Heng Y, Chen Y, Wang S, Yuan YH, et al. NLRP3 inflammasome activation in the thymus of MPTP-induced Parkinsonian mouse model. Toxicol Lett. 2018;288:1\u20138.","journal-title":"Toxicol Lett"},{"key":"209_CR44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417\u201326.","journal-title":"Mol Cell"},{"key":"209_CR45","doi-asserted-by":"crossref","first-page":"29874","DOI":"10.1074\/jbc.M203915200","volume":"277","author":"L Wang","year":"2002","unstructured":"Wang L, Manji GA, Grenier JM, Al-Garawi A, Merriam S, Lora JM, et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem. 2002;277:29874\u201380.","journal-title":"J Biol Chem"},{"key":"209_CR46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.intimp.2017.05.027","volume":"49","author":"QH Shao","year":"2017","unstructured":"Shao QH, Zhang XL, Yang PF, Yuan YH, Chen NH. Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome. Int Immunopharmacol. 2017;49:155\u201360.","journal-title":"Int Immunopharmacol"},{"key":"209_CR47","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1007\/s00018-012-1140-0","volume":"69","author":"I Hafner-Bratkovic","year":"2012","unstructured":"Hafner-Bratkovic I, Bencina M, Fitzgerald KA, Golenbock D, Jerala R. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1beta and neuronal toxicity. Cell Mol life Sci: CMLS. 2012;69:4215\u201328.","journal-title":"Cell Mol life Sci: CMLS"},{"key":"209_CR48","doi-asserted-by":"crossref","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, et al. Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS ONE. 2013;8:e55375.","journal-title":"PLoS ONE"},{"key":"209_CR49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Brundin P. Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder?. Mov Disord . 2013;28:31\u201340.","journal-title":"Mov Disord"},{"key":"209_CR50","first-page":"713517","volume":"2011","author":"D Litteljohn","year":"2010","unstructured":"Litteljohn D, Mangano E, Clarke M, Bobyn J, Moloney K, Hayley S. Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease. Parkinson\u2019s Dis. 2010;2011:713517.","journal-title":"Parkinson\u2019s Dis"},{"key":"209_CR51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molmed.2011.01.005","volume":"17","author":"SL Masters","year":"2011","unstructured":"Masters SL, O\u2019Neill LA. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. Trends Mol Med. 2011;17:276\u201382.","journal-title":"Trends Mol Med"},{"key":"209_CR52","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci: Off J Soc Neurosci. 2005;25:6016\u201324.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"209_CR53","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/eji.200940168","volume":"40","author":"F Martinon","year":"2010","unstructured":"Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol. 2010;40:616\u20139.","journal-title":"Eur J Immunol"},{"key":"209_CR54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrn3638","volume":"15","author":"JG Walsh","year":"2014","unstructured":"Walsh JG, Muruve DA, Power C. Inflammasomes in the CNS. Nat Rev Neurosci. 2014;15:84\u201397.","journal-title":"Nat Rev Neurosci"},{"key":"209_CR55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2015.05.011","volume":"135","author":"F Shi","year":"2015","unstructured":"Shi F, Kouadir M, Yang Y. NALP3 inflammasome activation in protein misfolding diseases. Life Sci. 2015;135:9\u201314.","journal-title":"Life Sci"},{"key":"209_CR56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","volume":"4","author":"KM Herrmann von","year":"2018","unstructured":"von Herrmann KM, Salas LA, Martinez EM, Young AL, Howard JM, Feldman MS, et al. NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis. 2018;4:24.","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"209_CR57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/toxsci\/kfx117","volume":"159","author":"EM Martinez","year":"2017","unstructured":"Martinez EM, Young AL, Patankar YR, Berwin BL, Wang L, von Herrmann KM, et al. Editor\u2019sHighlight: Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice. Toxicol Sci: Off J Soc Toxicol. 2017;159:64\u201375.","journal-title":"Toxicol Sci: Off J Soc Toxicol"},{"key":"209_CR58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160:62\u201373.","journal-title":"Cell"},{"key":"209_CR59","doi-asserted-by":"crossref","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, et al. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. 2018; 10(465). pii: eaah4066.\u00a0 http:\/\/stm.sciencemag.org\/content\/10\/465\/eaah4066.full","DOI":"10.1126\/scitranslmed.aah4066"},{"key":"209_CR60","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1236-z","volume":"15","author":"C Qiao","year":"2018","unstructured":"Qiao C, Zhang Q, Jiang Q, Zhang T, Chen M, Fan Y, et al. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP\/p mouse model of Parkinson\u2019s disease. J Neuroinflamm. 2018;15:193.","journal-title":"J Neuroinflamm"},{"key":"209_CR61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fnins.2018.00144","volume":"12","author":"S Omais","year":"2018","unstructured":"Omais S, Jaafar C, Ghanem N. \u201cTill Death Do Us Part\u201d: A potential irreversible link between aberrant cell cycle control and neurodegeneration in the adult olfactory bulb. Front Neurosci. 2018;12:144.","journal-title":"Front Neurosci"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0209-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0209-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0209-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:47Z","timestamp":1684616507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0209-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["209"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0209-1","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"24 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}